Antidepressants and suicide risk in children and adolescents weighing the evidence
Download
1 / 13

Antidepressants and Suicide Risk in Children and Adolescents: Weighing the Evidence - PowerPoint PPT Presentation


  • 141 Views
  • Uploaded on

Antidepressants and Suicide Risk in Children and Adolescents: Weighing the Evidence. Jill A. Morris, PA-S. Objectives/Goals . Review the current controversy regarding antidepressant use as treatment in child and adolescent patients with depression Review studies concerning:

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Antidepressants and Suicide Risk in Children and Adolescents: Weighing the Evidence' - monita


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Antidepressants and suicide risk in children and adolescents weighing the evidence

Antidepressants and Suicide Risk in Children and Adolescents: Weighing the Evidence

Jill A. Morris, PA-S


Objectives goals
Objectives/Goals Adolescents: Weighing the Evidence

  • Review the current controversy regarding antidepressant use as treatment in child and adolescent patients with depression

  • Review studies concerning:

    • The safety and efficacy of SSRIs in young patients

    • The risk of suicidal ideation associated with SSRIs in children and adolescent patients

    • Suicide attempts versus suicide deaths

  • Summary/Conclusions


Depression
Depression Adolescents: Weighing the Evidence


Background depression in children and adolescents
Background: Adolescents: Weighing the EvidenceDepression in Children and Adolescents

  • Depression is one of the most common diagnosable mental disorders in children and adolescents

  • Suicide is one of the risk factors associated with depression

  • SSRIs have been the “Gold Standard” for treating depression in children and adolescents

  • The downfall: SSRIs now have a warning regarding suicidality in children and adolescents

    • There is limited evidence supporting the safety (with concerns of suicidality) and efficacy of these drugs

    • Based on the extrapolation of data from adult studies


Study 1 the use of antidepressants to treat depression in children and adolescents
STUDY #1 Adolescents: Weighing the EvidenceThe Use of Antidepressants to Treat Depression in Children and Adolescents

  • Investigated the efficacy profiles of different antidepressants

  • Involved large RCT’s involving subjects 18 years old and younger with depression

  • Reviewed by the FDA:

    • 6 published reports

      • 3 of fluoxetine and 1 each of paroxetine, sertraline, and citalopram

    • 10 unpublished reports

      • 2 each of paroxetine, venlafaxine, nefazodone, and mirtazapine and 1 each of citalopram and escitalopram




Study 2 suicidality in pediatric patients treated with antidepressant drugs
STUDY #2 TrialsSuicidality in Pediatric Patients Treated with Antidepressant Drugs

  • Investigated the relationship between antidepressant drugs and suicidality in pediatric patients in randomized placebo-controlled trials

  • Data was derived from 4582 patients in 24 trials

    • 16 trials studied patients with MDD with the remaining 8 studied OCD (n=4), generalized anxiety disorder (n=2), and ADHD (n=1)

    • Only 20 trials were included in the risk ration analysis of suicidality because 4 trials had no events in the drug or placebo groups


Summary of the Overall Risk Ratio of the Primary Outcome by Drug Across all Indications and in MDD Trials


Study 3 antidepressant drug therapy and suicide in severely depressed children and adults
STUDY #3 Drug Across all Indications and in MDD TrialsAntidepressant drug therapy and suicide in severely depressed children and adults

  • Design: Case control study

  • Methods: Researchers used records to compare prescription histories between 263 children and teenagers (6-18 years) who had attempted suicide and 1241 controls who had never attempted suicide (all subjects suffered from depression)

  • Objective: To evaluate the risk of suicide death and serious suicide attempt in relation to antidepressant use



Summary
Summary with Antidepressant Treatment

  • Warnings include all antidepressant medications

  • Increase in suicidal ideation and behavior are relatively common in depression whereas completed suicides are far less common

    • It is common that a slight increase in ideation does not in fact increase actual completed suicides

  • Use of antidepressant drugs in pediatric patients is associated with a modestly increased risk of suicidality

    • The average risk of suicide ideation/behavioral tendencies in patients receiving antidepressants was 4%, twice the placebo risk of 2%; No suicides occurred in these trials

  • Fluoxetine is the only SSRI approved by FDA for use in children and adolescents and is the most efficacious and safest

  • Real world data does not suggest completed suicide rate has increased with greater antidepressant use

  • Causal association between antidepressants and suicide has not been confirmed; further studies are still needed to confirm of safety and efficacy in children and adolescents


References
References with Antidepressant Treatment

Cheung, Amy. The use of antidepressants to treat depression in children and adolescents. CMAJ. 2006; 174(2).

Clinical Advisory and Issue Analysis Regarding Antidepressant Use in Children and Adolescents. New Your State Office of Mental Health. 2004.

Hammad, Tarek A. Suicidality in Pediatric Patients Treated with Antidepressant Drugs. Archives of General Psychiatry. 2006; 63(3): 332-339.

Olfson, Mark. Antidepressant Drug Therapy and Suicide in Severely Depressed Children and Adults. Archives of General Psychiatry. 2006; 63(8): 865-872.

Rosack, Jim. Clinical Trials Controversy Spotlights Flawed System. American Psychiatric Association. 2004; 39(14): 1.

Son, Sung E. Depression in Children and Adolescents. American Academy of Family Physicians. 2000; 62(10): 2297-2308, 2311-2.

www.mhawinchester.org

www.nmha.org

www.wikipedia.org


ad